Work

Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half‐Opened

Year: 2018

Type: article

Abstract: Rizvi, Sumera M.B.B.S.1; Gores, Gregory J. M.D.1Editor(s): Corey, Kathleen E.2; Malhi, Harmeet3 Author Information

Source: Hepatology

DOI: 10.1002/hep.30069

Authors: Sumera I. Ilyas, Gregory J. Gores

Institution: Mayo Clinic

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Cholangiocarcinoma Foundation, Deutsche Forschungsgemeinschaft, Hans Böckler Stiftung, National Institutes of Health, Graduate Center, Center for Cell Signaling in Gastroenterology, Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G3928526, G473885138, G5348075755, G601308626, Mechanisms of Carcinogenesis in Biliary Epithelia, G9000352472

OpenAlex ID: W2801197329

FWCI: 0.236

Cites: 8

Cited by: 1

Related to: 10